image:Mitochondria being engulfed by autophagosome view more
Credit: Jlio C. B. Ferreira/USP
A study by Brazilian scientists points to the probable biological mechanism that modulates the accumulation of mutant mitochondrial DNA in cells during aging, especially in the liver. The mechanism is called autophagy, a process of cellular cleansing that destroys organelles, including mitochondria, and recycles their components. The findings resolve a paradigm in the field and raise a hypothesis for the emergence of diseases associated with mitochondrial DNA, paving the way for the development of therapies.
The study was supported by FAPESP and is reported in an articlepublishedin the journalAutophagy.
Mitochondria are responsible for cellular respiration, processing substrates to supply energy to the organism. They have their own genome inherited solely from the mother, unlike the DNA found in cell nuclei, which is inherited from both parents. Mitochondrial DNA is also subject to mutations, some of which can lead to diseases. According to estimates, disorders caused by mitochondrial DNA mutations affect at least one in every 5,000 people worldwide. One of these disorders is MELAS syndrome (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes), which can cause seizures, pain, altered consciousness and focal neurological deficits, among other symptoms.
Besides the disorders due directly to mitochondrial DNA mutations, there are others to which mutations contribute at least partly, saidMarcos Chiaratti, last author of the article. These include diabetes, Parkinsons and Alzheimers, he added, indicating that the study could pave the way for treatments involving autophagy in the context of different diseases.
Chiaratti is a professor in the Department of Genetics and Evolution at the Federal University of So Carlos (UFSCar) in So Paulo state. The other authors of the article are researchers affiliated with UFSCar and the University of So Paulo (USP) in Brazil, and with Cedars-Sinai Medical Center and Stanford University in the United States. The study was led by Chiaratti and supported by FAPESP via seven projects (16/07868-4,17/05899-2,17/04372-0,18/20028-0,20/15412-6,19/25049-9, and12/50231-6).
Research has shown that mitochondrial DNA mutations build up as part of aging. One of the oldest questions in biomedicine is why this is so, Chiaratti said. Theories that blame mitochondrial DNA replication or cell proliferation have been ruled out by previous studies. Given the importance of autophagy in the life cycle of cells and mitochondrial recycling, Chiaratti and colleagues decided to see if it played a role in mitochondrial DNA mutations. Autophagy is in vogue. The scientific literature on the topic is growing, he said. The 2016 Nobel Prize in Physiology or Medicine was awarded to Japanese cell biologist Yoshinori Ohsumi for his discoveries relating to autophagy mechanisms.
Practically all humans have a small amount of mutant DNA. The coexistence of mutant and wild-type (non-mutant) mitochondrial DNA in a cell is called heteroplasmy. In this study, Chiaratti et al. used mice with heteroplasmy at 30%: a mutant strain known as NZB/BINJ (or NZB) accounted for 30% of their mitochondrial genome, while the rest was C57BL/6N (or BL6), considered normal.
The researchers cross-bred these mice with others that lacked the geneatg7specifically in the liver. Without this gene, the requisite machinery to make autophagy possible simply disappears. We spent almost a year just on breeding, Chiaratti said.
After this period, they had two groups of mice: a control group with NZB mitochondrial DNA and the geneatg7; and a group with NZB but without the geneatg7in liver cells, so that autophagy in the liver was impossible (liver-specificatg7knockout).
Experiments were conducted to see if autophagy affected the buildup of mutant mitochondrial DNA over time. Ten days after birth, similar levels of NZB were found in the tissue of both groups of mice, but after 21 days NZB began to accumulate in the livers of the control animals, while the knockout group had the same proportion as before. After 100 days, when mice are considered adults, the controls had even higher levels of NZB while the knockouts had practically the same levels as when they were born, making the difference between the two groups even more evident and suggesting that autophagy plays a role in the age-related buildup of mutant mitochondrial DNA.
The researchers then set out to validate this finding by conducting an experiment with mice that lacked the genePrkn, which is responsible for a specific stage of autophagy. InPrknknockout mice, autophagy occurred but was defective. We again compared these mice with the controls, Chiaratti said. Although thePrknknockout mice did eventually accumulate NZB mitochondrial DNA, the buildup was smaller than for the control group. This reinforced the theory that autophagy is involved since manipulation of another gene associated with it led to changes in the data.
The researchers also found that autophagy mostly cleared BL6 mitochondrial DNA in controls, which presumably explained the higher levels of NZB. On exploring this possibility further, they discovered that the presence of NZB enhanced mitochondrial respiratory capacity in liver cells. We, therefore, postulated that autophagy might help eliminate less functional mitochondria while conserving the fittest, which of course would be positive, Chiaratti said.
Another stage of the study entailed isolation of fibroblasts, a type of connective tissue cell, from the mice, and the in vitro observation that NZB mitochondrial DNA levels in them fell over time. However, when drugs that stimulated autophagy were applied, the decline was reversed. This was further evidence of the importance of autophagy to mitochondrial DNA regulation, Chiaratti said.
While NZB was considered mutant in the mice involved in these experiments, the results show that it is not detrimental to the liver. On the contrary, it enhances mitochondrial respiratory capacity in liver cells, as already noted. Now we need to investigate the phenomenon with different mitochondrial DNAs that are known to be pathological, Chiaratti said.
If autophagy also proves relevant in this context, the researchers can begin to test treatments that stimulate the cell cleansing mechanism against diseases affected by the functioning of mitochondria. Other possibilities for future research, Chiaratti added, will include the role of autophagy in mitochondrial DNA accumulation in tissue elsewhere in the body apart from the liver and isolated fibroblasts.
About So Paulo Research Foundation (FAPESP)
The So Paulo Research Foundation (FAPESP) is a public institution with the mission of supporting scientific research in all fields of knowledge by awarding scholarships, fellowships and grants to investigators linked with higher education and research institutions in the State of So Paulo, Brazil. FAPESP is aware that the very best research can only be done by working with the best researchers internationally. Therefore, it has established partnerships with funding agencies, higher education, private companies, and research organizations in other countries known for the quality of their research and has been encouraging scientists funded by its grants to further develop their international collaboration. You can learn more about FAPESP atwww.fapesp.br/enand visit FAPESP news agency atwww.agencia.fapesp.br/ento keep updated with the latest scientific breakthroughs FAPESP helps achieve through its many programs, awards and research centers. You may also subscribe to FAPESP news agency athttp://agencia.fapesp.br/subscribe.
Autophagy deficiency abolishes liver mitochondrial DNA segregation
- Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy - PR Newswire - August 6th, 2022
- FDA halts testing of Beam's base editing cancer therapy - BioPharma Dive - August 6th, 2022
- OHSU advancing first-of-its-kind strategy to overcome infertility - OHSU News - August 6th, 2022
- Viral Vectors Manufacturing Market: Increase in the Number of Gene Therapy Candidates due to Rapid Development of Diseases to Drive the Market -... - August 6th, 2022
- The association of APOE genotype with COVID-19 disease severity | Scientific Reports - Nature.com - August 6th, 2022
- Revolutionizing Healthcare Testing: 1health Unveils Next Generation Diagnostic Platform that Enables Precision Medicine at Scale - Business Wire - August 6th, 2022
- Omega Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress - PR Newswire - August 6th, 2022
- Reshaping how doctors and researchers share phenotypic information: first GA4GH standard published by ISO - EurekAlert - August 6th, 2022
- Research Spots Gene That Raises Alzheimer's Risk for Women - HealthDay News - July 4th, 2022
- If You Have This Blood Type, Be Worried About Your Health Eat This Not That - Eat This, Not That - July 4th, 2022
- The NRC HL Holmes Award supports the development of technology to target and treat basal-like breast cancer - National Research Council Canada -... - July 4th, 2022
- UT Health San Antonio on global team discovering Alzheimers clues - San Antonio Report - July 4th, 2022
- Identities in harmony | Penn Today - Penn Today - July 4th, 2022
- The Global Genotyping Market size is expected to reach $30.9 billion by 2028, rising at a market growth of 14.7% CAGR during the forecast period -... - July 4th, 2022
- VA research will bring precision medicine to mental health - VAntage Point - VAntage Point Blog - June 11th, 2022
- Immatics and Editas Medicine Enter Strategic Research Collaboration and Licensing Agreement to Combine Gamma-Delta T Cell Adoptive Cell Therapies and... - June 11th, 2022
- First-of-its-Kind Stem Cell and Gene Therapy Highlighted at Annual Stem Cell Meeting - Newswise - June 11th, 2022
- UC develops new lung cancer treatment | University Of Cincinnati - University of Cincinnati - June 11th, 2022
- CTGT transactions: Beware of ripples in the safe harbor - JD Supra - June 11th, 2022
- Startup offers genetic testing that promises to predict healthiest embryo - WHYY - June 11th, 2022
- WHRY Funds Studies on Sex Differences in Treating Gastrointestinal Cancers, Bone Health in Transgender Youth, and the Greater Risk for Alzheimer's... - June 11th, 2022
- NIH awards USC more than $16 million for research on vascular dysfunction and Alzheimer's disease | Keck School of Medicine of USC - University of... - June 11th, 2022
- Effect of Metformin on Glycemic Control | DMSO - Dove Medical Press - June 11th, 2022
- Overcoming the Challenges of Cell and Gene Therapy Facilities - Genetic Engineering & Biotechnology News - June 3rd, 2022
- Organoids test gene therapies for Pitt-Hopkins syndrome - Spectrum - June 3rd, 2022
- Gene Therapy Successfully Treats Spinal Cord Injuries Without Side Effects - SciTechDaily - June 3rd, 2022
- The secret to a longer lifespan? Gene regulation holds a clue - EurekAlert - June 3rd, 2022
- Labcorp Expands Access to Comprehensive Genomic Testing Through New Lung Cancer Program - Business Wire - June 3rd, 2022
- Regenerative Medicine Market To Grow At A CAGR Of 11.27% By 2027, Due To Advancements In Cell Biology, Genomics Research, And Gene-Editing Technology... - June 3rd, 2022
- Foundation Medicine Partners with Lung Cancer Research Foundation and the Lung Cancer Mutation Consortium on Screening Trial to Enable Precision... - June 3rd, 2022
- Vertex and CRISPR Therapeutics Announce Acceptance of Late-Breaking Abstract for CTX001 at the 2022 Annual European Hematology Association (EHA)... - June 3rd, 2022
- Expression Patterns and Corepressor Function of Retinoic Acid-induced 2 in Prostate Cancer - DocWire News - June 3rd, 2022
- Winship receives $11 million grant from the National Cancer Institute to improve immunotherapy for lung cancer - EurekAlert - June 3rd, 2022
- Gene Editing Service Market Report 2022-2028 | Keyplayers- Caribou Biosciences, CRISPR Therapeutics, Merck KGa, Editas Medicine The Greater... - June 3rd, 2022
- Illumina to showcase the transformational impact of comprehensive genomic profiling in unlocking precision medicine for cancer patients, at ASCO -... - June 3rd, 2022
- The secret to a longer lifespan? Gene regulation holds a clue - University of Rochester - May 28th, 2022
- Welsh wins 2022 Shaw Prize in Life Sciences and Medicine | Carver College of Medicine - The University of Iowa - May 28th, 2022
- Episode 2: Are We Any Closer to Intestinal Gene Therapy in Crohn's Disease? - Medscape - May 28th, 2022
- Middle East Team Calls for Local Availability of Rapid WGS to Diagnose Severely Ill Infants - GenomeWeb - May 28th, 2022
- The Efficacy of Japanese Herbal Kampo Medicine as an Acute and Prophylactic Medication to Treat Chronic Daily Headache and Medication Overuse... - May 28th, 2022
- Breast cancer in man unexpectedly diagnosed after chest pain - The Columbus Dispatch - May 28th, 2022
- While the fetal clock develops, moms behaviour tells the time - The Daily Star - May 28th, 2022
- Foundation Medicine and Collaborators to Share More Than 20 Abstracts Featuring New Data at the 2022 American Society of Clinical Oncology Annual... - May 28th, 2022
- Illumina Introduces New Pan-Cancer Companion Diagnostic to Match Patients with Rare Genetic Mutations to Targeted Therapy - BioSpace - May 28th, 2022
- Project SG100K: DNA of 100000 Singaporeans to be mapped to identify new ways to prevent diseases - The Straits Times - May 28th, 2022
- Elevation Oncology Announces FDA Fast Track Designation Granted to Seribantumab for the Tumor-Agnostic Treatment of Solid Tumors Harboring NRG1 Gene... - May 28th, 2022
- INOVIO Announces Survival Results for INO-5401 + INO-9012 in Combination with Libtayo (cemiplimab) in Patients with Newly Diagnosed GBM at ASCO Annual... - May 28th, 2022
- Outlook on the Single-use Technologies for Biopharmaceuticals Global Market to 2026 - Increasing Demand for Personalized Medicine is Driving Growth -... - May 28th, 2022
- Bostons Seaport gets new cell and gene therapy research center, more to come - Boston Herald - May 17th, 2022
- The CasPlus Gene Editing Platform Technology can Correct Mutations Associated with Duchenne's Muscular Dystrophy and Cystic Fibrosis with High... - May 17th, 2022
- Genascence Announces Data From Phase 1 Clinical Trial on GNSC-001, Company's Lead Program in Osteoarthritis, Presented at American Society of Gene... - May 17th, 2022
- Will we be able to check cholesterol using gene editing technology or will it be too dangerous and costly to even try? - L'Observateur - L'Observateur - May 17th, 2022
- DiNAQOR Opens DiNAMIQS Subsidiary to Partner with Gene Therapy Companies Bringing New Treatments to Patients - PR Newswire - May 17th, 2022
- Ultragenyx Acquires Global Rights to AAV Gene Therapy ABO-102 for Sanfilippo Syndrome Type A (MPS IIIA) from Abeona Therapeutics - GlobeNewswire - May 17th, 2022
- This Gene Mutation Breaks the Immune System. Why Has It Survived? - WIRED - May 17th, 2022
- BRCA Experts Rally to Research DNA Repair for Better Breast, Ovarian and Other Cancer Treatments - Yale School of Medicine - May 17th, 2022
- AskBio to Present 11 Abstracts at Upcoming American Society of Gene and Cell Therapy's 25th Annual Meeting - PR Newswire - May 17th, 2022
- Protein linked to intellectual disability has complex role Washington University School of Medicine in St. Louis - Washington University School of... - May 17th, 2022
- CU School of Medicine Research Defines the Role of HDAC6 in Regulating Heart Stiffness - University of Colorado Anschutz Medical Campus - May 17th, 2022
- Emendo Biotherapeutics' next generation CRISPR gene editing technologies achieve breakthrough results with allele-specific approach for ELANE-related... - May 17th, 2022
- Latest Human Cells Atlas reveals more of the unknown world inside our bodies - EL PAS in English - May 17th, 2022
- Middle-East precision medicine market was estimated to be at $3,942.6 million in 2021, which is expected to grow with a CAGR of 7.37% and reach... - May 17th, 2022
- CANbridge-UMass Chan Medical School Gene Therapy Research to be Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting -... - May 6th, 2022
- Editas Medicine to Present Pipeline and Platform Data Demonstrating Progress Towards Developing Transformative Gene Editing Medicines at the American... - May 6th, 2022
- Top 12 emerging gene and cell therapy technologies likely to impact patient care announced in annual Disruptive Dozen from Mass General Brigham -... - May 6th, 2022
- Generation Bio Reports Business Highlights and First Quarter 2022 Financial Results - GlobeNewswire - May 6th, 2022
- BioMarin to Present Findings from Ongoing Studies of Valoctocogene Roxaparvovec, Investigational Gene Therapy, at the World Federation of Hemophilia... - May 6th, 2022
- Athenex, Texas Childrens Cancer Center, and the Center for Cell and Gene Therapy at Baylor College of Medicine to Present Phase 1 Clinical Data for... - May 6th, 2022
- The gene-edited pig heart given to a dying patient was infected with a pig virus - MIT Technology Review - May 6th, 2022
- WMIF panel: How cell and gene therapy can overcome limitations of CAR T - MedCity News - May 6th, 2022
- Promising results shown in the treatment of growth-hormone resistant dwarfism - EurekAlert - May 6th, 2022
- New treatment for infants with weakened immune systems - Sciworthy - May 6th, 2022
- Bioinformatics Market Size, Share, And Trends Analysis Report, By Application (Drug Development, Protein Function Analysis, Gene Therapy, Molecular... - May 6th, 2022
- Opus Genetics Announces Promising New Data Highlighting Potential of AAV-based Gene Therapies for the Treatment of Rare Inherited Retinal Diseases -... - May 6th, 2022
- A very specific kind of brain cell dies off in people with Parkinson's - Science News Magazine - May 6th, 2022
- Gene Editing Tools Market by 2029 Thermofisher Scientific, CRISPR Therapeutics, Editas Medicine Queen Anne and Mangolia News - Queen Anne and... - May 6th, 2022
- Sleep deprivation may increase the risk of eye disease - Medical News Today - May 6th, 2022
- Parkinson's Foundation Announces Major Expansion of PD GENEration Study, Increasing Access to Genetic Testing and Counseling Across the US - PR... - May 3rd, 2022
- Graphite Bio Announces U.S. FDA Fast Track Designation Granted to GPH101 for the Treatment of Sickle Cell Disease - Yahoo Finance - May 3rd, 2022
- Sangamo Therapeutics to Present Data From Its Next-Generation Technologies at 2022 Annual Meeting of the American Society of Gene & Cell Therapy... - May 3rd, 2022